Assessing Immunogenicity of Biologic Drugs in Inflammatory Joint Diseases: Progress Towards Personalized Medicine

por Gehin, Johanna Elin, Goll, Guro Løvik, Brun, Marthe Kirkesæther, Jani, Meghna, Bolstad, Nils, Syversen, Silje Watterdal
Publicado 2022

Risk factors for anti‐drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial

por Brun, Marthe Kirkesæther, Goll, Guro Løvik, Jørgensen, Kristin Kaasen, Sexton, Joseph, Gehin, Johanna Elin, Sandanger, Øystein, Olsen, Inge Christoffer, Klaasen, Rolf Anton, Warren, David John, Mørk, Cato, Kvien, Tore K., Jahnsen, Jørgen, Bolstad, Nils, Haavardsholm, Espen A., Syversen, Silje Watterdal
Publicado 2022